Form 4: Teladoc Health Executive Sells Shares

Kelly Bliss, President of Teladoc Health's U.S. Group Health, reported transactions involving the sale of common stock to cover tax withholding obligations.

Summary

• Kelly Bliss, President of U.S. Group Health at Teladoc Health, Inc., reported transactions on June 1st and June 2nd, 2026.
• These transactions involved the acquisition and subsequent sale of common stock.
• Specifically, 1,300 performance stock units were acquired, and 4,858 and 9,152 restricted stock units were acquired.
• A total of 7,679 shares were sold on June 2nd, 2026, at a price of $7.627 per share.
• These sales were to cover tax withholding obligations related to the vesting of performance and restricted stock units.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as the transactions are routine for executive compensation and tax management, rather than indicative of significant positive or negative sentiment about the company's prospects.

Positives

• Vesting of performance stock units and restricted stock units indicates continued equity-based compensation for the executive.
• The executive continues to hold a significant number of shares (92,378) after the reported transactions.

Negatives

• The executive sold shares, which could be interpreted as a lack of confidence, although it was to cover tax obligations.
• The sale price of $7.627 per share may be lower than the executive's acquisition cost or the perceived value of the stock.

Risks

• The company's stock price performance may continue to be volatile, impacting the value of outstanding equity awards.
• Future vesting schedules and potential tax implications could lead to further share sales by management.

Future Outlook

The filing does not contain forward-looking statements or guidance. It solely reports on past transactions.

Management Comments

• Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard for reporting insider transactions. The reported transactions for Teladoc Health (TDOC) are typical for executives managing tax liabilities associated with equity compensation vesting.

Stakeholder Impact

• Shareholders: The sale of shares by an executive, even for tax purposes, can sometimes be perceived negatively, though the context here is standard.
• Employees: The vesting of equity awards for executives like Kelly Bliss highlights the company's compensation structure.
• Management: The transaction reflects the standard practice of managing tax liabilities associated with equity compensation.

Next Steps

• Continued vesting of performance and restricted stock units as per the grant and award schedules.
• Potential future sales of stock by the reporting person to cover tax obligations as awards continue to vest.

Key Dates

Keywords

Form 4, SEC Filing, Teladoc Health, TDOC, Insider Trading, Stock Sale, Executive Compensation, Restricted Stock Units, Performance Stock Units, Tax Withholding